Nephrada · IGAN · United Kingdom · Renal pathologist · captured by Dr. Anna Becker on 10 May 2026 · reviewed by Dr. Sophie Laurent on 11 May 2026
Verbatim as captured; never edited
Renal pathologist at Guy's and St Thomas' raised treatment burden and fatigue during a advisory board. They indicated this influences their current prescribing approach.
Human-approved by Dr. Sophie Laurent on 11 May 2026
Treatment burden and fatigue: recurring question reported by renal pathologist (GB).
helixor-private-llm-2026.05 · generated 10 May 2026, 10:00 UTC
AI summary
Treatment burden and fatigue raised by renal pathologist; relevant for Medical Affairs.
Source spans used by the model
Renal pathologist at Guy's and St Thomas' raised treatment burden and fatigue during a advisory board. They indicated this influences their current prescribing approach.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Education need | Education need |
| Function | Medical Affairs | Medical Affairs |
| Priority | Low | Low |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 1 | 20% | 4.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 2 | 10% | 4.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 3 | 5% | 3.0 |
| Breadth of occurrence | 1 | 5% | 1.0 |
| Total | Low 43 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
08 May 2026 · Dr. Gabriel Rossi, Guy's and St Thomas' · MSL Dr. Anna Becker
Insight
Reviewed 11 May 2026 by Dr. Sophie Laurent
Action
Initiative
Decision
Outcome
Closure
Duplicate theme merged into strategic objective review.